SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 125 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $172 | -23.6% | 4,575 | 0.0% | 0.00% | 0.0% |
Q1 2024 | $225 | +34.7% | 4,575 | 0.0% | 0.00% | 0.0% |
Q4 2023 | $167 | -98.5% | 4,575 | -97.9% | 0.00% | -96.6% |
Q3 2023 | $11,141 | +9184.2% | 214,601 | +4590.7% | 0.03% | +2800.0% |
Q2 2023 | $120 | +1.7% | 4,575 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $118 | -0.8% | 4,575 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $119 | -99.9% | 4,575 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $131,000 | +15.9% | 4,575 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $113,000 | -56.2% | 4,575 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $258,000 | -9.2% | 4,575 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $284,000 | -2.1% | 4,575 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $290,000 | -23.1% | 4,575 | 0.0% | 0.00% | -50.0% |
Q2 2021 | $377,000 | +11.9% | 4,575 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $337,000 | +1.5% | 4,575 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $332,000 | – | 4,575 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |